Michelle Scurr
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Oncology top 2%
- Gastroenterology top 1%
- Surgery top 10%
- Co-authors
- Ian JudsonJaap VerweijM. van GlabbekeRobin L. JonesAxel Le CesneJean‐Yves BlayStefan SleijferSandrine Marréaud
- Topics
- Sarcoma Diagnosis and Treatment (29 papers)Vascular Tumors and Angiosarcomas (19 papers)Gastrointestinal Tumor Research and Treatment (8 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Michelle Scurr
56 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 1.0k
- Oncology 1.0k
- Gastroenterology 514
- Surgery 462
Countries citing papers authored by Michelle Scurr
This map shows the geographic impact of Michelle Scurr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Scurr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Scurr more than expected).
Fields of papers citing papers by Michelle Scurr
This network shows the impact of papers produced by Michelle Scurr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Scurr. The network helps show where Michelle Scurr may publish in the future.
Co-authorship network of co-authors of Michelle Scurr
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Scurr. A scholar is included among the top collaborators of Michelle Scurr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Scurr. Michelle Scurr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 41 | |
| 3 | 20 | |
| 4 | 43 | |
| 5 | 47 | |
| 6 | 72 | |
| 7 | 50 | |
| 8 | 39 | |
| 9 | 36 | |
| 10 | 7 | |
| 11 | Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)breakdown → | 535 |
| 12 | 269 | |
| 13 | Expression of XPG mRNA and protein as potential biomarker of response to trabectedin in sarcoma patients | 2 |
| 14 | 2 | |
| 15 | 16 | |
| 16 | 60 | |
| 17 | 158 | |
| 18 | 20 | |
| 19 | 44 | |
| 20 | 15 |
About Michelle Scurr
Michelle Scurr is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 56 papers that have together received 3.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (29 papers), Vascular Tumors and Angiosarcomas (19 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). The work is most often cited by research in Gastroenterology (514 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Oncology (1.0k citations). Michelle Scurr has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Ian Judson, Jaap Verweij, M. van Glabbeke, Robin L. Jones, Axel Le Cesne, Jean‐Yves Blay, Stefan Sleijfer, Sandrine Marréaud, Lini Pandite and Omar Al‐Muderis. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.